These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29632747)

  • 21. Outcome of Hypofractionated Palliative Radiotherapy Regimens for Patients With Advanced Head and Neck Cancer in Tikur Anbessa Hospital, Ethiopia: A Prospective Cohort Study.
    Zingeta GT; Worku YT; Awol M; Woldetsadik ES; Assefa M; Chama TZ; Feyisa JD; Bedada HF; Adem MI; Mengesha T; Wong R
    JCO Glob Oncol; 2024 Jan; 10():e2300253. PubMed ID: 38181315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monthly palliative pelvic radiotherapy in advanced carcinoma of uterine cervix.
    Mishra SK; Laskar S; Muckaden MA; Mohindra P; Shrivastava SK; Dinshaw KA
    J Cancer Res Ther; 2005; 1(4):208-12. PubMed ID: 17998655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
    Akimoto T; Muramatsu H; Takahashi M; Saito J; Kitamoto Y; Harashima K; Miyazawa Y; Yamada M; Ito K; Kurokawa K; Yamanaka H; Nakano T; Mitsuhashi N; Niibe H
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1033-9. PubMed ID: 15519772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour bleeding: Efficacy and outcome of haemostatic radiotherapy.
    Kumar P; Rastogi K; Dana R; Rakesh A; Bairwa SC; Bhaskar S
    Natl Med J India; 2019; 32(6):342-344. PubMed ID: 33380626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
    Yeoh EE; Fraser RJ; McGowan RE; Botten RJ; Di Matteo AC; Roos DE; Penniment MG; Borg MF
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):943-55. PubMed ID: 12605972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?
    Hortelano E; Gómez-Iturriaga A; Ortiz-de-Zárate R; Zaballa M; Barturen Á; Casquero F; San-Miguel Í; Carvajal C; Cacicedo J; Del-Hoyo O; Lupiani J; Pérez F; Bilbao P
    Rev Esp Enferm Dig; 2014 Mar; 106(3):165-70. PubMed ID: 25007015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study.
    Kondoh C; Shitara K; Nomura M; Takahari D; Ura T; Tachibana H; Tomita N; Kodaira T; Muro K
    BMC Palliat Care; 2015 Aug; 14():37. PubMed ID: 26238344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors.
    Aoshika T; Abe T; Iino M; Saito S; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki YU; Noda SE; Kato S
    Anticancer Res; 2022 Dec; 42(12):6099-6103. PubMed ID: 36456125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.
    Quon H; Cheung PC; Loblaw DA; Morton G; Pang G; Szumacher E; Danjoux C; Choo R; Thomas G; Kiss A; Mamedov A; Deabreu A
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):898-905. PubMed ID: 21237581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.
    Tey J; Back MF; Shakespeare TP; Mukherjee RK; Lu JJ; Lee KM; Wong LC; Leong CN; Zhu M
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):385-8. PubMed ID: 17118569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of split-course hypofractionated palliative radiotherapy in head and neck cancer.
    Kancherla KN; Oksuz DC; Prestwich RJ; Fosker C; Dyker KE; Coyle CC; Sen M
    Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):141-8. PubMed ID: 20934860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
    Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study.
    Shibuki T; Sasaki M; Yamaguchi S; Inoue K; Taira T; Satake T; Watanabe K; Imaoka H; Mitsunaga S; Fujisawa T; Tomizawa K; Oyoshi H; Nakamura M; Hojo H; Ikeda M
    Radiat Oncol; 2023 Oct; 18(1):178. PubMed ID: 37907912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moderately Hypofractionated Radiotherapy in Node-positive Prostate Cancer.
    Mallick I; Das A; Arunsingh M
    Clin Oncol (R Coll Radiol); 2019 Apr; 31(4):260-264. PubMed ID: 30718087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3 Gy/fraction).
    Valeriani M; Marinelli L; Nicosia L; Reverberi C; De Sanctis V; Mollo D; Osti MF
    Radiol Med; 2019 Dec; 124(12):1324-1332. PubMed ID: 31317381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.